Halcyon Organics bases our claims on the medical benefits of cannabis on reputable clinical research and studies. This list represents only a small sample of 1000’s of positive clinical studies. We will update this resource as our doctors find more data.
The following studies demonstrate cannabis’ important medicinal value. The old ‘marijuana drug war’ propaganda warned us that “there are over 100 chemicals in marijuana.” This is true. What they didn’t mention was that those hundreds of chemicals hold cures and treatments to some of mankind’s most insidious diseases.
Each link directs to the study described by the title. We have categorized the studies based upon what disease they treat. Some studies prove medical efficacy for multiple conditions. This is some hard-core nerd stuff so open a browser tab and get a dictionary website ready.
The following studies prove that cannabis is a neuroprotectant and AChE inhibitor. This is what makes medical marijuana superior treatment for neurodegenerative conditions like Alzheimer’s Disease and dementia. These studies also prove efficacy in treating Chronic Traumatic Encephalopathy (CTE) caused from head injuries. CTE is the condition that is causing NFL players to commit suicide.
Alzheimer’s Disease, Dementia, CTE:
The influence of cannabinoids on generic traits of neurodegeneration
Cannabinoids are Neuroprotective in human tissue samples_JNeurosci
Regulatory role of the CB2 for Inflammation
Cannabidiol as Emergent Therapeutic Strategy – Free Rad Biol Med_2012
Whole Plant Extracts Improve Neurogenic Symptoms – Clinical Rehab
Modulating the Endocannabinoid system in Human Health – FEBS_2013
A Molecular Link Between Marijuana and Alzheimer’s Disease Pathology
Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation
CBD Neuroprotection in pigs Neuropharmacology_2013
CBD prevents cerebral infarction in mice_Stroke_2005
Transdermal-delivery-of-cannabidiol-attenuates-alcohol-induced-neurodegeneration_2013
Cannabinoids New Promising Agents in the Treatment of Neurological Diseases
Cannabidiol and other cannabinoids reduce microglial activation in relevance to Alzheimer’s disease
PTSD:
Endocannabinoid System as a target to treat PTSD
CBD, Non-psychoactive Cannabis Sativa constituent, as anxiolytic drug
Epilepsy:
CBD Displays Anti Epileptiform and Antiseizure Properties In Vitro and In Vivo
Cannabidivarin (CBDV) suppresses PTZ-induced increases in epilepsy-relate gene expression
Cannabidivarin (CBDV) is Anticonvulsant in Mouse and Rat
Multiple sclerosis:
Whole plant cannabis extracts for treatment of spasticity in MS
Cannabinoid Modulation of Neuroinflammatory Disorders
CBD inhibits pathogenic T cell, decreases spinal microglial multiple sclerosis
Symptomatic therapy in multiple sclerosis – The of cannabinoids
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
therapeutic effects experimental autoimmune encephalomyelitis
Cancer:
Cannabidiol Induces Programmed Cell Death in Breast Cancer
Cannabidiol as Anti-cancer Drug
Cannabidiol Inhibits Lung Cancer Cell Invasion and Metastasis
CBD Inhibits Angiogenesis by Multiple Mechanisms
Cannabis Extract Treatment for Terminal Acute Leukemia
CBD Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma
Tumor Apoptosis in Colon Cancer
Antitumor Effects of Cannabidiol on Human Glioma Cell Lines
Combined Therapy of Cannabinoids and Temozolomide against Glioma
Cannabidiol Antitumor activity on Breast Cancer
Cannabinoids Reduce Breast Cancer Progression
Cannabidiol reduces breast cancer cell proliferation, invasion, metastasis
Endocannabinoid anandamide inhibits breast cancer cell proliferation
THC inhibits epithelial growth factor induced lung cancer cell migration
Cannabidiol CBD inhibits lung cancer cell invasion metastasis
Cannabinoid Receptors inhibit non-small cell lung cancer growth and metastasis
Non-THC cannabinoids inhibit prostate carcinoma growth
Cannabinoid receptor-mediated apoptosis in Mantle Cell Lymphoma
CB1 and CB2 receptor activation inhibits Non-Hodgkin Lymphoma growth
THC induces apoptosis in Jurkat Leukemia
Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells
Anti-tumoral action of cannabinoids on hepatocellular carcinoma
Diabetes:
Impact of marijuana on diabetes in adults
HIV/AIDS and Anti-virals:
Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus
Osteoporosis and bone disorders:
Endocannabinoids regulate bone metabolism
Cannabinoid Receptors as Target for Treatment of Osteoporosis
Antibacterial (Kills infectious disease like MRSA):
Antibacterial Cannabinoids from Cannabis Sativa
CB1 receptor antagonist inhibits macrophage infection
Fibromyalgia:
Cannabis treatment in fibromyalgia patients
Crohn’s Disease:
Cannabis Induces Clinical Response in Crohn’s Disease
Cannabinoids Alleviate Intestinal Inflammation
Studies Citing Cannabis’ Overall Medicinal Benefits:
Therapeutic aspects of cannabis and cannabinoids
Cannabidiol in Humans as Therapeutic Targets
Cannabinoids in Health and Disease
Cannabis and endocannabinoid modulators – Therapeutic promises and challenges
Cannabis synergy and phytocannabinoid-terpenoid entourage effects
Miscellaneous conditions (pain, liver, kidney, vascular, inflammation):
Endocannabinoid System and Pain
Cannabidiol Protects Against Hepatic Ischemia
Cannabidiol vs Aspirin and Tramadol
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration
Human Endocannabinoid System (ECS)
Clinical Endocannabinoid Deficiency Syndrome
Endocannabinoid Anxiety and Depression
Phytocannabinoids and CB1 and CB2 receptors
